Möhle, R., Pförsich, M., Frühauf, S., Witt, B., Krämer, A., & Haas, R. (1994). Filgrastim post-chemotherapy mobilizes more CD34+ cells with a different antigenic profile compared with use during steady-state hematopoiesis. Bone marrow transplantation, 14(5), .
Chicago-Zitierstil (17. Ausg.)Möhle, Robert, Margit Pförsich, Stefan Frühauf, Barbara Witt, Alwin Krämer, und Rainer Haas. "Filgrastim Post-chemotherapy Mobilizes More CD34+ Cells with a Different Antigenic Profile Compared with Use During Steady-state Hematopoiesis." Bone Marrow Transplantation 14, no. 5 (1994).
MLA-Zitierstil (9. Ausg.)Möhle, Robert, et al. "Filgrastim Post-chemotherapy Mobilizes More CD34+ Cells with a Different Antigenic Profile Compared with Use During Steady-state Hematopoiesis." Bone Marrow Transplantation, vol. 14, no. 5, 1994.